| Metric | Value |
|---|---|
| Action | BUY on pullback / HOLD if owned |
| Conviction Level | MEDIUM-HIGH (7/10) |
| Investment Classification | INVESTMENT (with reservations) |
| Position Size | 4-5% (Neutral) / 2-3% (Conservative) |
| Entry Price | Current: $208.91 / Ideal: $199-203 |
| Target Price | $260-300 (12-18 months) |
| Stop Loss | $195-199 (depending on risk tolerance) |
The Allstate Corporation (ALL) represents a quality franchise trading at value prices following a successful turnaround from 2022-2023 catastrophe losses. With a trailing P/E of 6.5x, 35% ROE, and 38% margin of safety to intrinsic value, the stock offers compelling value metrics. However, the stock's proximity to 52-week highs ($214.88), 74% analyst bullishness, and significant CEO insider selling ($50M+) create unfavorable near-term risk/reward.
The Graham Verdict: Allstate passes 5 of 7 defensive investor criteria but fails the critical 10-year earnings stability test (2022-2023 losses) and P/B ratio threshold (2.15 vs 1.5 max). This makes it a speculative-grade investment for conservative investors but an acceptable investment for enterprising investors with adequate margin of safety.
Recommended Strategy: Use a tiered entry approach. Buy 25-40% of intended position now, add on pullbacks to the 50-day SMA ($203.72) and 200-day SMA ($199.27). Do not chase above $210.
| Metric | Value | Graham Threshold | Status |
|---|---|---|---|
| P/E Ratio (TTM) | 6.54-6.77 | ≤15 | PASS |
| P/B Ratio | 2.05-2.15 | ≤1.5 | FAIL |
| P/E × P/B | 14.1-17.4 | ≤22.5 | PASS |
| Earnings Stability (10yr) | 8/10 years positive | 10/10 | FAIL |
| Dividend Record | 30+ years | 20+ years | PASS |
| Adequate Size | $55B market cap | >$100M | PASS |
| Financial Condition | D/E 0.32 | Strong | PASS |
Graham Number: $214.21 (stock trading 2.5% below) Intrinsic Value (DCF): $342 (38% margin of safety) ROE: 34-35% (exceptional)
Verdict: INVESTMENT with reservations. The failed earnings stability test is concerning but attributable to industry-wide catastrophe events rather than business deterioration.
| Indicator | Value | Signal |
|---|---|---|
| Trend (50/200 SMA) | Golden Cross | BULLISH |
| RSI (14) | 55.15 | NEUTRAL (cooling from overbought) |
| MACD | Above signal line | BULLISH |
| Price vs 200-day SMA | +4.84% | BULLISH |
| Distance to 52-week High | -2.8% | CAUTION |
Key Levels:
Timing Signal: WAIT for pullback. RSI was overbought (76) just 5 days ago. Let the correction complete to improve entry.
| Factor | Score | Interpretation |
|---|---|---|
| Analyst Ratings | 74% Buy | CONTRARIAN CAUTION |
| Insider Activity | CEO selling $50M+ | BEARISH |
| News Sentiment | 85% positive | CONTRARIAN CAUTION |
| Social Sentiment | Low activity | NEUTRAL |
| Institutional Ownership | 81% | BULLISH |
Mr. Market Assessment: OPTIMISTIC (72/100)
Contrarian Signal: When nearly everyone is bullish, who is left to buy? Current sentiment suggests limited near-term upside and elevated correction risk. Graham would advise patience.
Core Thesis: Allstate is a generational opportunity to buy a dominant insurance franchise at bargain prices. The market is stuck on 2022-2023 losses that were industry-wide events, not business deterioration.
Key Arguments:
Upside Target: $300-420 (44-101% upside)
Core Thesis: Allstate trades near all-time highs with multiple Graham red flags. Buyers at current prices face asymmetric downside risk from climate-driven catastrophes and earnings normalization.
Key Arguments:
Downside Target: $130-165 (21-38% downside)
CONDITIONAL BULL VICTORY
The 38% margin of safety tilts the debate in favor of bulls, but the bears raise valid concerns about entry timing and quality metrics. The appropriate response is not aggressive accumulation but disciplined, tiered buying on pullbacks.
| Profile | Position Size | Entry Strategy |
|---|---|---|
| Conservative | 2-3% | Wait for $199 or below |
| Neutral | 4-5% | Tiered: 25% now, 75% on dips |
| Aggressive | 6-8% | Tiered: 40% now, 60% on dips |
| Level | Price | Purpose |
|---|---|---|
| Stop Loss | $195-199 | Below 200-day SMA; disaster protection |
| Target 1 | $225-240 | Analyst consensus |
| Target 2 | $260-280 | Near intrinsic value |
| Target 3 | $300+ | Multiple expansion |
| Scenario | Probability | Target | Return |
|---|---|---|---|
| Bear Case | 20% | $165 | -21% |
| Base Case | 50% | $260 | +24% |
| Bull Case | 30% | $320 | +53% |
| Expected Value | - | $263 | +26% |
| Criterion | Assessment | Status |
|---|---|---|
| Thorough Analysis Performed | Comprehensive multi-agent analysis | PASS |
| Safety of Principal Established | 38% margin of safety, fortress balance sheet | PASS |
| Adequate Return Expected | 15% earnings yield, 1.9% dividend, 26% expected return | PASS |
Classification: INVESTMENT (with reservations for conservative investors due to failed earnings stability test)
Tier 1 (25% of position): Buy at current price ($208-210)
Tier 2 (35% of position): Buy at 50-day SMA ($203-204)
Tier 3 (40% of position): Buy at 200-day SMA ($199-200)
| Metric | Value |
|---|---|
| Current Price | $208.91 |
| Market Cap | $55.05B |
| P/E (TTM) | 6.54-6.77 |
| Forward P/E | 10.98 |
| P/B Ratio | 2.05-2.15 |
| EPS (TTM) | $30.84-$31.31 |
| Dividend Yield | 1.91% |
| Dividend (Annual) | $4.00 |
| ROE | 34-35% |
| Beta | 0.24-0.26 |
| 52-Week Range | $173.06 - $214.88 |
| Metric | Value |
|---|---|
| Graham Number | $214.21 |
| Intrinsic Value (DCF) | $342 |
| Margin of Safety | 38% |
| P/E × P/B | 14.1-17.4 |
| Book Value/Share | $95.95-$104.98 |
| Rating | Count |
|---|---|
| Strong Buy | 8 |
| Buy | 12 |
| Hold | 6 |
| Sell | 1 |
| Strong Sell | 0 |
| Consensus | Moderate Buy |
| Avg Target | $236.60 |
| High Target | $300 |
This analysis is for educational purposes only and does not constitute financial advice. Past performance does not guarantee future results. Insurance stocks carry inherent catastrophe risk. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Analysis prepared following Benjamin Graham's value investing methodology as outlined in "The Intelligent Investor"